Chinese english Germany Japanese Korea

TAT (48 - 57)

TAT (48 - 57) Struktur
253141-50-3
CAS-Nr.
253141-50-3
Englisch Name:
TAT (48 - 57)
Synonyma:
TAT (48 - 57);TAT (48-57) TFA salt;L-Arginine, glycyl-L-arginyl-L-lysyl-L-lysyl-L-arginyl-L-arginyl-L-glutaminyl-L-arginyl-L-arginyl-
CBNumber:
CB63148044
Summenformel:
C55H109N31O12
Molgewicht:
1396.65
MOL-Datei:
253141-50-3.mol
Request For Quotation

TAT (48 - 57) Eigenschaften

Dichte
1.55±0.1 g/cm3(Predicted)
Aggregatzustand
Solid
Farbe
White to off-white
Sequenz
H-Ile-Tyr-Leu-Gly-Gly-Pro-Phe-Ser-Pro-Asn-Val-Leu-OH

Sicherheit

TAT (48 - 57) Chemische Eigenschaften,Einsatz,Produktion Methoden

TAT (48 - 57) Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

TAT (48 - 57) Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 35)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Shenzhen Nexconn Pharmatechs Ltd 		+86-755-89396905 +86-15013857715
 admin@nexconn.com China 10259 58
Career Henan Chemica Co 		+86-0371-86658258 15093356674;
 laboratory@coreychem.com China 30254 58
BOC Sciences 		16314854226; +16314854226
 inquiry@bocsci.com United States 19743 58
Zhejiang J&C Biological Technology Co.,Limited 		+1-2135480471 +1-2135480471
 sales@sarms4muscle.com China 10522 58
Zhejiang Hangyu API Co., Ltd 		+8617531972939
 anna@api-made.com China 2944 58
Zibo Hangyu Biotechnology Development Co., Ltd 		+86-0533-2185556 +8617865335152
 Mandy@hangyubiotech.com China 11012 58
Chembest Research Laboratories Limited 021-20908456
sales@BioChemBest.com China 6008 61
Creative Peptides
info@creative-peptides.com United States 6084 56
Hangzhou Peptidego Biotech Co.,Ltd. 0571-87213919
eric@peptidego.com China 6526 58
Beijing xinyanhui pharmaceutical research and development co., LTD 13969155946
 1461866103@qq.com China 16111 58
  • TAT (48 - 57)
  • TAT (48-57) TFA salt
  • L-Arginine, glycyl-L-arginyl-L-lysyl-L-lysyl-L-arginyl-L-arginyl-L-glutaminyl-L-arginyl-L-arginyl-
  • 253141-50-3
Copyright 2019 © ChemicalBook. All rights reserved